GTC Biotherapeutics (fka GTCB)

[DewDiligence]

The overall framework of the GTC-LFB deal is a 50/50 split of costs and profits. Some posters here are losing sight of this and focusing unduly on ways that LFB might try to screw GTC out of its fair share of the pie.

This collaboration obviously has many moving parts, some of which can’t be fully described yet. It will clearly require good faith on the part of both participants to make it work.

As previous posted (#msg-13727339), I’m not a big fan of this kind of open-ended collaboration and I would have preferred a set of tighter, more focused partnerships. Nevertheless, I see no justification for investors to assume that there will be some kind of bad faith effort by LFB.